Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb.

Ogba N, Chaplin LJ, Doughman YQ, Fujinaga K, Montano MM.

Cancer Res. 2008 Sep 1;68(17):7015-24. doi: 10.1158/0008-5472.CAN-08-0814.

2.

HEXIM1 and the control of transcription elongation: from cancer and inflammation to AIDS and cardiac hypertrophy.

Dey A, Chao SH, Lane DP.

Cell Cycle. 2007 Aug 1;6(15):1856-63. Epub 2007 Jun 6. Review.

PMID:
17671421
3.

Brd4 and HEXIM1: multiple roles in P-TEFb regulation and cancer.

Chen R, Yik JH, Lew QJ, Chao SH.

Biomed Res Int. 2014;2014:232870. doi: 10.1155/2014/232870. Epub 2014 Jan 29. Review.

4.

Expanding role of cyclin dependent kinases in cytokine inducible gene expression.

Brasier AR.

Cell Cycle. 2008 Sep 1;7(17):2661-6. Epub 2008 Sep 12. Review.

5.

Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development.

Manavathi B, Samanthapudi VS, Gajulapalli VN.

Front Cell Dev Biol. 2014 Aug 12;2:34. doi: 10.3389/fcell.2014.00034. eCollection 2014. Review.

6.

What's new in estrogen receptor action in the female reproductive tract.

Hewitt SC, Winuthayanon W, Korach KS.

J Mol Endocrinol. 2016 Feb;56(2):R55-71. doi: 10.1530/JME-15-0254. Review.

7.

The cerebellum as a target for estrogen action.

Hedges VL, Ebner TJ, Meisel RL, Mermelstein PG.

Front Neuroendocrinol. 2012 Oct;33(4):403-11. doi: 10.1016/j.yfrne.2012.08.005. Epub 2012 Sep 5. Review.

Supplemental Content

Support Center